Stockscreener 앱 받기
0.7803
1.59%
0.0122
전일 마감가:
$0.7681
열려 있는:
$0.76
하루 거래량:
16,276
Relative Volume:
0.12
시가총액:
$22.59M
수익:
$26.55M
순이익/손실:
$-91.72M
주가수익비율:
-0.2177
EPS:
-3.584
순현금흐름:
$-13.25M
1주 성능:
+5.39%
1개월 성능:
-2.03%
6개월 성능:
-40.44%
1년 성능:
-64.53%
1일 변동 폭
$0.75
$0.8436
1주일 범위
$0.74
$0.8436
52주 변동 폭
$0.5601
$4.35
Celularity Inc Stock (CELU) Company Profile
명칭
Celularity Inc
전화
(908) 768-2170
주소
170 PARK AVE, FLORHAM PARK
Compare CELU vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
0.7803 | 22.23M | 26.55M | -91.72M | -13.25M | -3.584 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-30 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-06-22 | 개시 | H.C. Wainwright | Buy |
| 2022-04-06 | 다운그레이드 | Truist | Buy → Hold |
| 2022-01-28 | 개시 | Oppenheimer | Outperform |
| 2021-11-24 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Celularity Inc 주식(CELU)의 최신 뉴스
Press Release: Celularity Appoints Rick Gonzalez as Chief Commercial Officer - Moomoo
Number of shareholders of Celularity Inc. – NASDAQ:CELUW - TradingView
CELU Q4 2025 Earnings: Narrower-Than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Celularity Inc. Warrant 2021-16.07.26 on Celularity -A- Financial Disclosures & SEC Filings - TradingView
Celularity Inc. Announces Resignation of Vincent LeVien as Director, Effective June 26, 2026 - marketscreener.com
Celularity Inc. Enters into a Loan Agreement with the Philip & Daniele Barach Family Trust - marketscreener.com
Celularity Company Profile & Introduction - Moomoo
Celularity Inc. Secures $1 Million Loan from Philip & Daniele Barach Family Trust – Form 8-K Filing Details and Key Agreement Terms 141519 - Minichart
CELULARITYSECURES $1 MLN LOAN FROM PHILIP & DANIELE BARACH FAMILY TRUSTSEC FILING - Moomoo
Celularity director Vincent LeVien resigns from board - TradingView
Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term - Stock Titan
Celularity Inc (NASDAQ: CELU) Share Price, CELU Stock News, CELU Share Price & Updates - Kalkine
Enterprise value to EBIT forward of Celularity Inc. – NASDAQ:CELU - TradingView
Enterprise value to EBITDA forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to sales forward of Celularity Inc. – NASDAQ:CELU - TradingView
Price to earnings forward of Celularity Inc. – NASDAQ:CELU - TradingView
Celularity Appoints Chief Operating Officer - Moomoo
Celularity Strengthens Leadership With New Executive Appointments - The Globe and Mail
Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary - TradingView
New leadership at Celularity (NASDAQ: CELU) as Gordon joins board - Stock Titan
Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU) - TradingView
Celularity Inc. (CELU) Q4 2025 Earnings: Narrowed Loss Beats Estimates, but Revenue Remains AbsentDiluted EPS Report - DonanımHaber
Form 4 Celularity Inc For: 23 June By Investing.com - Investing.com South Africa
Barach Family Trust (CELU) lets $2M note, warrant options lapse while holding large derivatives - Stock Titan
Celularity (NASDAQ: CELU) insider trust sees $2M note option expire - Stock Titan
Celularity (NASDAQ: CELU) major holder’s $2M note option and 839K warrants expire - Stock Titan
Form 13D/A Celularity Inc. For: 23 June By Investing.com - Investing.com Australia
Barach Family Trust updates 15.8% Celularity (CELU) stake in 13D/A - Stock Titan
CELU Technical Analysis & Stock Price Forecast - Intellectia AI
Penny Stocks: Why Is Celularity (CELU) Stock Trending Today? - TipRanks
Celularity Inc (CELU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELUW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Celularity Inc (CELUW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Celularity Inc (CELUW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Celularity Inc (CELUW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELUW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELUW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Celularity Inc (CELUW) Institutional Confidence - TradingKey
Celularity Inc (CELUW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity Inc (CELU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Celularity Inc (CELU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Celularity Inc (CELU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Celularity Inc (CELU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Celularity Inc (CELU) Institutional Confidence - TradingKey
Celularity Inc. Warrant (CELUW) Holds at $0.01 Amid Minimal Volatility – Key Levels in FocusPCR Moving Average - newsline.com
Celularity Faces Nasdaq Listing Compliance Risk After Notice - The Globe and Mail
Celularity Inc. 8-K Filing June 2026: Nasdaq Listing, Company Details, and Securities Information - Minichart
Celularity Inc (CELU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Celularity Inc 주식 (CELU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Haines John R | Senior Exec Vice President |
Apr 13 '26 |
Option Exercise |
0.00 |
1,641 |
0 |
30,762 |
| Hariri Robert J | Chief Executive Officer |
Apr 13 '26 |
Option Exercise |
0.00 |
3,281 |
0 |
2,854,735 |
0.80%
2.11%
자본화:
|
볼륨(24시간):